Assessment of the control measures of the category A diseases of Animal Health Law: Rift Valley Fever

Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Helen Clare Roberts; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Simon Gubbins; Alessandro Broglia; Inma Aznar; Yves Van der Stede; EFSA Panel on Animal Health and Welfare (AHAW)

doi:10.2903/j.efsa.2022.7070

Assessment of the control measures of the category A diseases of Animal Health Law: Rift Valley Fever

Søren Saxmose Nielsen, Julio Alvarez, Dominique Joseph Bicout, Paolo Calistri, Elisabetta Canali, Julian Ashley Drewe, Bruno Garin-Bastuji, José Luis Gonzales Rojas, Christian Gortázar, Mette Herskin, Virginie Michel, Miguel Ángel Miranda Chueca, Helen Clare Roberts, Barbara Padalino, Paolo Pasquali, Hans Spoolder, Karl Ståhl, Antonio Velarde Calvo, Arvo Viltrop, Christoph WincklerSimon Gubbins, Alessandro Broglia, Inma Aznar, Yves Van der Stede, EFSA Panel on Animal Health and Welfare (AHAW)

Department of Animal and Veterinary Sciences - ANIVET Behaviour, stress and welfare (BSW)

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

2 Citations (Scopus)

Abstract

EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases ('Animal Health Law'). This opinion belongs to a series of opinions where these control measures were assessed for several diseases, with this opinion covering the assessment of control measures for Rift Valley Fever (RVF). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period and (iii) the minimum radius of the protection and surveillance zone and the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere; nonetheless, the transmission kernels used for the assessment of the minimum radius of the protection and surveillance zones are shown. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. Different risk-based sampling procedures based on clinical visits and laboratory testing are assessed in case of outbreak suspicion, granting animal movements and for repopulation purposes. The length of monitoring period and minimum duration of measures to be implemented in the restricted zones as defined in the Delegated Regulation (30 days) are considered effective for the investigation and control of suspected and confirmed RVF outbreaks, as well as the size of protection and surveillance zone of 20 and 50 km, respectively, which are assessed as sufficient to contain disease transmission with at least 95% probability.

Original language	English
Article number	e07070
Journal	EFSA Journal
Volume	20
Issue	1
ISSN	1831-4732
DOIs	https://doi.org/10.2903/j.efsa.2022.7070
Publication status	Published - Jan 2022

Keywords

Disease control measures
Rift Valley Fever, RVF
monitoring period
protection zone
sampling procedures
surveillance zone

Access to Document

10.2903/j.efsa.2022.7070Licence: CC BY-ND

Check availability with the Royal Danish Library

Cite this

Nielsen, S. S., Alvarez, J., Bicout, D. J., Calistri, P., Canali, E., Drewe, J. A., Garin-Bastuji, B., Gonzales Rojas, J. L., Gortázar, C., Herskin, M., Michel, V., Miranda Chueca, M. Á., Roberts, H. C., Padalino, B., Pasquali, P., Spoolder, H., Ståhl, K., Calvo, A. V., Viltrop, A., ... EFSA Panel on Animal Health and Welfare (AHAW) (2022). Assessment of the control measures of the category A diseases of Animal Health Law: Rift Valley Fever. EFSA Journal, 20(1), Article e07070. https://doi.org/10.2903/j.efsa.2022.7070

@article{5e5912fc7ca5491298802f9adfd56ba7,

title = "Assessment of the control measures of the category A diseases of Animal Health Law: Rift Valley Fever",

abstract = "EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases ('Animal Health Law'). This opinion belongs to a series of opinions where these control measures were assessed for several diseases, with this opinion covering the assessment of control measures for Rift Valley Fever (RVF). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period and (iii) the minimum radius of the protection and surveillance zone and the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere; nonetheless, the transmission kernels used for the assessment of the minimum radius of the protection and surveillance zones are shown. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. Different risk-based sampling procedures based on clinical visits and laboratory testing are assessed in case of outbreak suspicion, granting animal movements and for repopulation purposes. The length of monitoring period and minimum duration of measures to be implemented in the restricted zones as defined in the Delegated Regulation (30 days) are considered effective for the investigation and control of suspected and confirmed RVF outbreaks, as well as the size of protection and surveillance zone of 20 and 50 km, respectively, which are assessed as sufficient to contain disease transmission with at least 95% probability.",

keywords = "Disease control measures, Rift Valley Fever, RVF, monitoring period, protection zone, sampling procedures, surveillance zone",

author = "Nielsen, {S{\o}ren Saxmose} and Julio Alvarez and Bicout, {Dominique Joseph} and Paolo Calistri and Elisabetta Canali and Drewe, {Julian Ashley} and Bruno Garin-Bastuji and {Gonzales Rojas}, {Jos{\'e} Luis} and Christian Gort{\'a}zar and Mette Herskin and Virginie Michel and {Miranda Chueca}, {Miguel {\'A}ngel} and Roberts, {Helen Clare} and Barbara Padalino and Paolo Pasquali and Hans Spoolder and Karl St{\aa}hl and Calvo, {Antonio Velarde} and Arvo Viltrop and Christoph Winckler and Simon Gubbins and Alessandro Broglia and Inma Aznar and {Van der Stede}, Yves and {EFSA Panel on Animal Health and Welfare (AHAW)}",

year = "2022",

month = jan,

doi = "10.2903/j.efsa.2022.7070",

language = "English",

volume = "20",

journal = "EFSA Journal",

issn = "1831-4732",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "1",

}

Nielsen, SS, Alvarez, J, Bicout, DJ, Calistri, P, Canali, E, Drewe, JA, Garin-Bastuji, B, Gonzales Rojas, JL, Gortázar, C, Herskin, M, Michel, V, Miranda Chueca, MÁ, Roberts, HC, Padalino, B, Pasquali, P, Spoolder, H, Ståhl, K, Calvo, AV, Viltrop, A, Winckler, C, Gubbins, S, Broglia, A, Aznar, I, Van der Stede, Y & EFSA Panel on Animal Health and Welfare (AHAW) 2022, 'Assessment of the control measures of the category A diseases of Animal Health Law: Rift Valley Fever', EFSA Journal, vol. 20, no. 1, e07070. https://doi.org/10.2903/j.efsa.2022.7070

Assessment of the control measures of the category A diseases of Animal Health Law: Rift Valley Fever. / Nielsen, Søren Saxmose; Alvarez, Julio; Bicout, Dominique Joseph et al.
In: EFSA Journal, Vol. 20, No. 1, e07070, 01.2022.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

TY - JOUR

T1 - Assessment of the control measures of the category A diseases of Animal Health Law

T2 - Rift Valley Fever

AU - Nielsen, Søren Saxmose

AU - Alvarez, Julio

AU - Bicout, Dominique Joseph

AU - Calistri, Paolo

AU - Canali, Elisabetta

AU - Drewe, Julian Ashley

AU - Garin-Bastuji, Bruno

AU - Gonzales Rojas, José Luis

AU - Gortázar, Christian

AU - Herskin, Mette

AU - Michel, Virginie

AU - Miranda Chueca, Miguel Ángel

AU - Roberts, Helen Clare

AU - Padalino, Barbara

AU - Pasquali, Paolo

AU - Spoolder, Hans

AU - Ståhl, Karl

AU - Calvo, Antonio Velarde

AU - Viltrop, Arvo

AU - Winckler, Christoph

AU - Gubbins, Simon

AU - Broglia, Alessandro

AU - Aznar, Inma

AU - Van der Stede, Yves

AU - EFSA Panel on Animal Health and Welfare (AHAW)

PY - 2022/1

Y1 - 2022/1

N2 - EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases ('Animal Health Law'). This opinion belongs to a series of opinions where these control measures were assessed for several diseases, with this opinion covering the assessment of control measures for Rift Valley Fever (RVF). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period and (iii) the minimum radius of the protection and surveillance zone and the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere; nonetheless, the transmission kernels used for the assessment of the minimum radius of the protection and surveillance zones are shown. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. Different risk-based sampling procedures based on clinical visits and laboratory testing are assessed in case of outbreak suspicion, granting animal movements and for repopulation purposes. The length of monitoring period and minimum duration of measures to be implemented in the restricted zones as defined in the Delegated Regulation (30 days) are considered effective for the investigation and control of suspected and confirmed RVF outbreaks, as well as the size of protection and surveillance zone of 20 and 50 km, respectively, which are assessed as sufficient to contain disease transmission with at least 95% probability.

AB - EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases ('Animal Health Law'). This opinion belongs to a series of opinions where these control measures were assessed for several diseases, with this opinion covering the assessment of control measures for Rift Valley Fever (RVF). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period and (iii) the minimum radius of the protection and surveillance zone and the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere; nonetheless, the transmission kernels used for the assessment of the minimum radius of the protection and surveillance zones are shown. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. Different risk-based sampling procedures based on clinical visits and laboratory testing are assessed in case of outbreak suspicion, granting animal movements and for repopulation purposes. The length of monitoring period and minimum duration of measures to be implemented in the restricted zones as defined in the Delegated Regulation (30 days) are considered effective for the investigation and control of suspected and confirmed RVF outbreaks, as well as the size of protection and surveillance zone of 20 and 50 km, respectively, which are assessed as sufficient to contain disease transmission with at least 95% probability.

KW - Disease control measures

KW - Rift Valley Fever, RVF

KW - monitoring period

KW - protection zone

KW - sampling procedures

KW - surveillance zone

UR - http://www.scopus.com/inward/record.url?scp=85125321031&partnerID=8YFLogxK

U2 - 10.2903/j.efsa.2022.7070

DO - 10.2903/j.efsa.2022.7070

M3 - Journal article

C2 - 35079289

SN - 1831-4732

VL - 20

JO - EFSA Journal

JF - EFSA Journal

IS - 1

M1 - e07070

ER -

Assessment of the control measures of the category A diseases of Animal Health Law: Rift Valley Fever

Abstract

Keywords

Access to Document

Check availability with the Royal Danish Library

Other files and links

Fingerprint

Cite this